Biotechnology research continues to churn out new drugs addressing genetic drivers of cancer. While that progress gives patients more treatment options, one limitation of this approach is it takes for ...

This Q&A is part of a weekly series of posts highlighting common questions encountered by technophiles and answered by users at Stack Exchange, a free, community-powered network of 100+ Q&A sites.

Recursion, Roche, and its Genentech subsidiary have unveiled a whole-genome map of specialized microglial immune cells that they plan to use toward revealing significant new targets in ...